CIK: 0001855655 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $2,183,398 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 5,269,433 | $373,708 | 17.1% | $60.72 | +28.8% | COM | 670703107 |
| ACLX | ARCELLX INC | 4,492,032 | $294,677 | 13.5% | $40.87 | +65.8% | COMMON STOCK | 03940C100 |
| RVMD | REVOLUTION MEDICINES INC | 6,178,111 | $218,458 | 10.0% | $36.46 | +11.3% | COM | 76155X100 |
| ONC | BEIGENE LTD | 666,024 | $181,272 | 8.3% | $203.25 | — | SPONSORED ADS | 07725L102 |
| — | MERUS N V | 3,369,699 | $141,831 | 6.5% | $49.84 | — | COM | N5749R100 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,610,197 | $134,086 | 6.1% | $26.31 | +87.9% | COM | 87650L103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 4,394,556 | $96,680 | 4.4% | $22.36 | +17.3% | COM | 28036F105 |
| JANX | JANUX THERAPEUTICS INC | 3,329,909 | $89,908 | 4.1% | $48.02 | -21.5% | COM | 47103J105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,946,168 | $65,274 | 3.0% | $25.46 | +46.7% | COM | 22663K107 |
| PCVX | VAXCYTE INC | 1,696,481 | $64,059 | 2.9% | $85.06 | -6.0% | COM | 92243G108 |
| IRON | DISC MEDICINE INC | 1,210,971 | $60,113 | 2.8% | $48.64 | +14.3% | COM | 254604101 |
| COGT | COGENT BIOSCIENCES INC | 8,963,655 | $53,692 | 2.5% | $8.02 | -2.2% | COM | 19240Q201 |
| LENZ | LENZ THERAPEUTICS INC | 1,511,932 | $38,872 | 1.8% | $27.61 | -10.8% | COM | 52635N103 |
| APGE | APOGEE THERAPEUTICS INC | 961,707 | $35,929 | 1.6% | $48.22 | -19.8% | COM | 03770N101 |
| ARGX | ARGENX SE | 59,679 | $35,322 | 1.6% | $406.28 | — | SPONSORED ADR | 04016X101 |
| CYTK | CYTOKINETICS INC | 858,664 | $34,510 | 1.6% | $45.96 | 0.0% | COM NEW | 23282W605 |
| INSM | INSMED INC | 451,359 | $34,434 | 1.6% | $76.49 | 0.0% | COM PAR $.01 | 457669307 |
| SYRE | SPYRE THERAPEUTICS INC | 2,127,205 | $34,322 | 1.6% | $26.04 | -20.1% | COM NEW | 00773J202 |
| — | METSERA INC | 1,191,462 | $32,432 | 1.5% | $27.22 | — | COM | 59267L107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,095,079 | $28,242 | 1.3% | $19.19 | -11.2% | COM | 92790C104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 6,741,172 | $25,347 | 1.2% | $8.25 | -39.0% | COM | 68062P106 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 627,423 | $24,513 | 1.1% | $48.85 | -11.8% | CLASS A ORD | 61559X104 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1,465,334 | $22,918 | 1.0% | $14.09 | 0.0% | COM | 03969K108 |
| — | Y-MABS THERAPEUTICS INC | 4,236,346 | $18,767 | 0.9% | $14.19 | — | COM | 984241109 |
| ERAS | ERASCA INC | 10,802,354 | $14,799 | 0.7% | $2.37 | -27.6% | COM | 29479A108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 500,000 | $11,000 | 0.5% | $22.36 | +17.3% | Call | 28036F105 |
| OCUL | OCULAR THERAPEUTIX INC | 1,314,018 | $9,632 | 0.4% | $7.69 | 0.0% | COM | 67576A100 |
| IMTX | IMMATICS N.V | 1,907,108 | $8,601 | 0.4% | $9.89 | -47.3% | SHS | N44445109 |